Bamlanivimab / Etesevimab

Anticorpi monoclonali per COVID-19

Bibliografia - Quali fonti bibliografiche per Bamlanivimab / Etesevimab?

1. Agenzia Italiana del Farmaco – AIFA, Informativa per gli operatori sanitari, 2021 https://www.aifa.gov.it/documents/20142/1307084/Informativa%20hcp_combo.pdf (accesso: maggio 2021).


2. DrugBank, 2021 https://go.drugbank.com/drugs/DB15718 (accesso: maggio 2021).


3. Food and Drug Administration – FDA, Coronvirus (COVID-19): Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab, 2021, April 16 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab (accesso: maggio 2021).


4. Gottlieb R.L. et al., JAMA, 2021, 325 (7), 632.


5. Hurt A.C., Wheatley A.K., Viruses, 2021, 13 (4), 628.


6. Jones B.E. et al., Sci. Transl. Med., 2021, eabf1906.


7. LactMed, Etesevimab and Ballanivimab, 2021, 19 April https://pubmed.ncbi.nlm.nih.gov/33630482/ (accesso: maggio 2021).